Go Kaneko

Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma

M. Oyama, M. Yasuda, K. Nishimoto, 2022, AntiCancer Research.

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT‐BSI) study

K. Harada, K. Nakajima, H. Shiina, 2018, International journal of urology : official journal of the Japanese Urological Association.

Histological complete response with nivolumab for renal cell carcinoma with multiple metastases: A case report.

M. Oyama, K. Nagata, K. Nishimoto, 2018, Molecular and clinical oncology.

Delayed nivolumab‐induced hepatotoxicity during pazopanib treatment for metastatic renal cell carcinoma: An autopsy case

M. Oyama, K. Nishimoto, Taiki Hayashi, 2019, IJU case reports.

Lower neutrophil‐to‐lymphocyte ratio and positive programmed cell death ligand‐1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma

M. Yasuda, K. Nishimoto, Go Kaneko, 2022, Cancer medicine.

Laparoendoscopic single‐site simple nephrectomy and reduced port procedure for inflammatory nonfunctioning kidney

M. Oyama, S. Hara, S. Hattori, 2021, IJU case reports.

Reduced port laparoscopic radical nephrectomy using an umbilical zigzag skin incision for renal cell carcinoma

M. Oyama, S. Shirotake, K. Kanao, 2020, International Cancer Conference Journal.

Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.

K. Nakagawa, M. Oya, M. Oyama, 2019, Japanese journal of clinical oncology.